Endocrine

, Volume 29, Issue 3, pp 435–444 | Cite as

Patterns of gene expression in pituitary carcinomas and adenomas analyzed by high-density oligonucleotide arrays, reverse transcriptase-quantitative PCR, and protein expression

  • Katharina H. Ruebel
  • Alexey A Leontovich
  • Long Jin
  • Gail A. Stilling
  • Heyu Zhang
  • Xiang Qian
  • Nobuki Nakamura
  • Bernd W. Scheithauer
  • Kalman Kovacs
  • Ricardo V. Lloyd
Original Articles

Abstract

Very few of the genes that are important in pituitary tumor initiation, progression, and metastasis have been identified to date. To identify potential genes that may be important in pituitary tumor progression and carcinoma development, we used AffymetrixTM GeneChip HGU-133A-oligonucleotide arrays, which contain more than 15,000 characterized genes from the human genome to study gene expression in an ACTH pituitary carcinoma metastatic to the liver and four pituitary adenomas. Reverse-transcriptase real-time quantitative-PCR (RT-qPCR) was then used to analyze 4 nonneoplastic pituitaries, 19 adenomas, and the ACTH carcinoma. A larger series of pituitary adeno mas and carcinomas were also analyzed for protein expression using tissue microarrays (TMA) (n=233) and by Western blotting (n=18). There were 4298 genes that were differentially expressed among the adenomas compared to the carcinoma, with 2057 genes overexpressed and 2241 genes underexpressed in the adenomas. The betagalacioside binding protein galactin-3 was underexpressed in some adenomas compared to the carcinomas. Prolactin (PRL) and ACTH tumors had the highest levels of expression of galectin-3. The human achaetescute homolog-1 ASCL1 (hASH-1) gene was also underexpressed in some adenomas compared to the carcinoma. Prolactin and ACTH tumors had the highest levels of expression of hASH-1. ID2, which has an important role in cell development and tumorigenesis, was underexpressed in some adenomas compared to the carcinomas. Transducin-like enhancer of split four/Croucho (TLE-4) was over-expressed in adenomas compared to the ACTH carcinoma. The differential expression of these genes was validated by RT-qPCR, by immunohistochemistry using TMA and by Western blotting. These results indicate that the LGALS3, hASH1, ID2, and TLE-4 genes may have important roles in the development of pituitary carcinomas.

Key Words

DNA microarray pituitary carcinoma galectin-3 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Asa, S. L. and Ezzat, S. (2002). Nat. Rev. Cancer 2, 836–849.PubMedCrossRefGoogle Scholar
  2. 2.
    Landis, C. A., Masters, S. B., Spada, A., Pace, A. M., Bourne, H. R., and Vallar, L. (1989). Nature 340, 692–6961.PubMedCrossRefGoogle Scholar
  3. 3.
    Pei, L. and Melmed, S. (1997). Mol. Endocrinol. 11, 433–441.PubMedCrossRefGoogle Scholar
  4. 4.
    Zhang, X., Sun, H., Danila, D. C., et al (2002). J. Clin. Endocrinol. Metab. 87, 1262–1267.PubMedCrossRefGoogle Scholar
  5. 5.
    Zhang, X., Zhou, Y., Mehta, K. R., et al. (2003). J. Clin. Endocrinol. Metab. 88, 5119–5126.PubMedCrossRefGoogle Scholar
  6. 6.
    Lloyd, R. V. (2001). J. Neurooncol. 54, 111–119.PubMedCrossRefGoogle Scholar
  7. 7.
    Levy, A. and Lightman, S. (2003). Front. Neuroendocrinol. 24, 94–127.PubMedCrossRefGoogle Scholar
  8. 8.
    Woloschak, M., Yu, A., Xiao, J., and Post, K. D. (1996). Cancer Res. 56, 2493–2496.PubMedGoogle Scholar
  9. 9.
    Simpson, D. J., Clayton, R. N., and Farrell, W. E. (2003). Oncogene 21, 1217–1224.CrossRefGoogle Scholar
  10. 10.
    Simpson, D. J., Hibberts, N. A., McNicol, A. M., Clayton, R. N., and Farrell, W. E. (2000). Cancer Res. 60, 1211–1216.PubMedGoogle Scholar
  11. 11.
    Riss, D., Jin, L., Qian, X., et al. (2003). Cancer Res. 63, 2251–2255.PubMedGoogle Scholar
  12. 12.
    Ruebel, K. H., Jin, L., Qian, X., et al. (2005). Cancer Res. 65, 1136–1140.PubMedCrossRefGoogle Scholar
  13. 13.
    Qian, Z. R., Sano, T., Yoshimoto, K., et al. (2005). Lab. Invest. 85, 464–473.PubMedCrossRefGoogle Scholar
  14. 14.
    Zhao, J., Dahle, D., Zhou, Y., Zhang, X., and Klibanski, A. (2005). J. Clin. Endocrinol. Metab. 90, 2179–2186.PubMedCrossRefGoogle Scholar
  15. 15.
    Zhang, X., Horwitz, G. A., Heaney, A. P., et al. (1999). J. Clin. Endocrinol. Metab. 84, 761–767.PubMedCrossRefGoogle Scholar
  16. 16.
    Ishikawa, H., Heaney, A. P., Yu, R., Horwitz, G. A., and Melmed, S. (2001). J. Clin. Endocrinol. Metab. 86, 867–874.PubMedCrossRefGoogle Scholar
  17. 17.
    Pernicone, P. J., Scheithauer, B. W., Sebo, T. J., et al. (1997). Cancer 79, 804–812.PubMedCrossRefGoogle Scholar
  18. 18.
    Scheithauer, B. W., Kurtkaya-Yapicier, O., Kovacs, K. T., Young W. F. Jr., and Lloyd, R. V. (2005). Neurosurgery 56, 1066–1074; discussion 1066–1074.PubMedGoogle Scholar
  19. 19.
    Kaltsas, G. A., Nomikos, P., Kontogeorgos, G., Buchfelder, M., and Grossman, A. B. (2005). J. Clin. Endocrinol. Metab. 90, 3089–3099.PubMedCrossRefGoogle Scholar
  20. 20.
    Pei, L., Melmed, S., Scheithauer, B., Kovacs, K., and Prager, D. (1994). J. Clin. Endocrinol. Metab. 78, 842–846.PubMedCrossRefGoogle Scholar
  21. 21.
    Yu, R. and Melmed, S. (2001). Brain Pathol. 11, 328–341.PubMedCrossRefGoogle Scholar
  22. 22.
    Herman, V., Drazin, N. Z., Gonsky, R., and Melmed, S. (1993). J. Clin. Endocrinol. Metab. 77, 50–55.PubMedCrossRefGoogle Scholar
  23. 23.
    Goidin, D., Kappeler, L., Perrot, J., Epelbaum, J., and Gourdji, D. (2000). Endocrinology 141, 4805–4808.PubMedCrossRefGoogle Scholar
  24. 24.
    Wood, W. M., Sarapura, V. D., Dowding, J. M., et al. (2002). Endocrinology 143, 347–359.PubMedCrossRefGoogle Scholar
  25. 25.
    Mohammad, H. P., Seachrist, D. D., Quirk, C. C., and Nilson, J. H. (2004). Mol. Endocrinol. 18, 2583–2593.PubMedCrossRefGoogle Scholar
  26. 26.
    Evans, C. O., Young, A. N., Brown, M. R., et al. (2001). J. Clin. Endocrinol. Metab. 86, 3097–3107.PubMedCrossRefGoogle Scholar
  27. 27.
    Tanaka, S., Tatsumi, K., Okubo, K., et al. (2002). J. Mol. Endocrinol. 28, 33–44.PubMedCrossRefGoogle Scholar
  28. 28.
    Morris, D. G., Musat, M., Czirjak, S., et al. (2005). Eur. J. Endocrinol. 153, 143–151.PubMedCrossRefGoogle Scholar
  29. 29.
    Woo, Y., Affourtit, J., Daigle, S., et al. (2004). J. Biomol. Tech. 15, 276–284.PubMedGoogle Scholar
  30. 30.
    Tan, P. K., Downey, T. J., Spitznagel, E. L. Jr., et al. (2003). Nucleic Acids Res. 31, 5676–5684.PubMedCrossRefGoogle Scholar
  31. 31.
    Barondes, S. H., Cooper, D. N., Gitt, M. A., and Leffler, H. (1994). J. Biol. Chem. 269, 20807–20810.PubMedGoogle Scholar
  32. 32.
    Amado, M., Almeida, R., Schwientek, T., and Clausen, H. (1999). Biochim. Biophys. Acta 1473, 35–53.PubMedGoogle Scholar
  33. 33.
    Furukawa, K. and Sato, T. (1999). Biochim. Biophys. Acta 1473, 54–66.PubMedGoogle Scholar
  34. 34.
    Ochieng, J., Fridman, R., Nangia-Makker, P., et al. (1994). Biochemistry 33, 14109–14114.PubMedCrossRefGoogle Scholar
  35. 35.
    Nangia-Makker, P., Honjo, Y., Sarvis, R., et al. (2000). Am. J. Pathol. 156, 899–909.PubMedGoogle Scholar
  36. 36.
    Yoshii, T., Fukumori, T., Honjo, Y., Inohara, H., Kim, H. R., and Raz, A. (2002). J. Biol. Chem. 277, 6852–76857.PubMedCrossRefGoogle Scholar
  37. 37.
    Bresalier, R. S., Mazurek, N., Sternberg, L. R., et al. (1998). Gastroenterology 115, 287–296.PubMedCrossRefGoogle Scholar
  38. 38.
    Xu, X. C., el-Naggar, A. K., and Lotan, R. (1995). Am. J. Pathol. 147, 815–822.PubMedGoogle Scholar
  39. 39.
    Jin, L., Riss, D., Ruebel, K. H., et al. (2005). Endocr. Pathol. 16, 104–114.CrossRefGoogle Scholar
  40. 40.
    Salameh, B. A., Leffler, H., and Nilsson, U. J. (2005). Bioorg. Med. Chem. Lett. 15, 3344–3346.PubMedCrossRefGoogle Scholar
  41. 41.
    Guillemot, F., Lo, L. C., Johnson, J. E., Auerbach, A., Anderson, D. J., and Joyner, A. L. (1993). Cell 75, 463–476.PubMedCrossRefGoogle Scholar
  42. 42.
    Lo, L., Guillemot, F., Joyner, A. L., and Anderson, D. J. (1994). Perspect. Dev. Neurobiol. 2, 191–201.PubMedGoogle Scholar
  43. 43.
    Shida, T., Furuya, M., Nikaido, T., et al. (2005). Clin. Cancer Res. 11, 450–458.PubMedGoogle Scholar
  44. 44.
    Linnoila, R. I., Naizhen, X., Meuwissen, R., Berns, A., and DeMayo, F. J. (2005). Exp. Lung. Res. 31, 37–55.PubMedCrossRefGoogle Scholar
  45. 45.
    Ferretti, E., Di Stefano, D., Zazzeroni, F., et al. (2003). J. Endocrinol. Invest. 26, 957–965.PubMedGoogle Scholar
  46. 46.
    Jiang, S. X., Kameya, T., Asamura, H., et al. (2004). Mod. Pathol. 17, 222–229.PubMedCrossRefGoogle Scholar
  47. 47.
    Ruzinova, M. B. and Benezra, R. (2003). Trends Cell Biol. 13, 410–418.PubMedCrossRefGoogle Scholar
  48. 48.
    Sikder, H. A., Devlin, M. K., Dunlap, S., Ryu, B., and Alani, R. M. (2003). Cancer Cell 3, 525–530.PubMedCrossRefGoogle Scholar
  49. 49.
    Yokota, Y. and Mori, S. (2003). J. Cell Physiol. 190, 21–28.CrossRefGoogle Scholar
  50. 50.
    Kowanetz, M., Valcourt, U., Bergstrom, R., Heldin, C. H., and Moustakas, A. (2004). Mol. Cell Biol. 24, 4241–4254.PubMedCrossRefGoogle Scholar
  51. 51.
    Chen, G. and Courey, A. J. (2000). Gene 249, 1–16.PubMedCrossRefGoogle Scholar
  52. 52.
    Gasperowicz, M. and Otto, F. (2005). J. Cell Biochem. 95, 670–687.PubMedCrossRefGoogle Scholar
  53. 53.
    Dasen, J. S., Barbera, J. P., Herman, T. S., et al. (2001). Genes Dev. 15, 3193–3207.PubMedCrossRefGoogle Scholar
  54. 54.
    Douglas, K. R., Brinkmeier, M. L., Kennell, J. A., et al. (2001). Mamm. Genome 12, 843–851.PubMedCrossRefGoogle Scholar
  55. 55.
    Brinkmeier, M. L., Potok, M. A., Cha, K. B., et al. (2003). Mol. Endocrinol. 17, 2152–2161.PubMedCrossRefGoogle Scholar
  56. 56.
    Moreno, C. S., Evans, C. O., Shan, X., Okor, M., Desideno, D. M., and Oyesiku, N. M. (2005). Cancer Res. 65, 10214–10222.PubMedCrossRefGoogle Scholar
  57. 57.
    Kobayashi, I., Jin, L., Ruebel, K. H., Bayliss, J. M., Hidehiro, O., and Lloyd, R. V. (2003). Endocrine 22, 285–292.PubMedCrossRefGoogle Scholar
  58. 58.
    Horiguchi, H., Jin, L., Ruebel, K. H., Scheithauer, B. W., and Lloyd, R. V. (2004). Endocrine 24, 141–156.PubMedCrossRefGoogle Scholar
  59. 59.
    Mhawech, P., Berczy, M., Assaly, M., et al. (2004). Ant. J. Clin. Pathol. 122, 100–105.CrossRefGoogle Scholar
  60. 60.
    Dang, J., Inukai, T., Kurosawa, H., et al. (2001). Mol. Cell Biol. 21, 5935–5945.PubMedCrossRefGoogle Scholar
  61. 61.
    Jin, L., Zhang, S., Bayliss, J., et al. (2003). Endocr. Pathol. 14, 37–48.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press Inc. 2006

Authors and Affiliations

  • Katharina H. Ruebel
    • 1
  • Alexey A Leontovich
    • 1
  • Long Jin
    • 1
  • Gail A. Stilling
    • 1
  • Heyu Zhang
    • 1
  • Xiang Qian
    • 1
  • Nobuki Nakamura
    • 1
  • Bernd W. Scheithauer
    • 1
  • Kalman Kovacs
    • 2
  • Ricardo V. Lloyd
    • 1
  1. 1.Department of Laboratory Medicine and PathologyMayo Clinic College of MedicineRochester
  2. 2.St. Michael's HospitalUniversity of Toronto, St. Michael's HospitalToronto

Personalised recommendations